허혈 재관류 손상 예방 및/또는 치료용 한약 조성물

본 발명은 단삼 살비아놀산, 삼칠 사포닌, 황기 사포닌으로 구성된 허혈 재관류 손상 예방 및/또는 치료용 한약 조성물을 개시한다. The present invention discloses a traditional Chinese medicinal composition for preventing and/or treating ischemia reperfusion injury; the traditional Chinese medicinal composition consists of salvianolic acids, Panax Notogins...

Full description

Saved in:
Bibliographic Details
Main Authors ZHOU SHUIPING, HUANG DANDAN, MA XIAOHUI, HE YI, CHEN QINGFANG, HAN JINGYAN
Format Patent
LanguageKorean
Published 15.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:본 발명은 단삼 살비아놀산, 삼칠 사포닌, 황기 사포닌으로 구성된 허혈 재관류 손상 예방 및/또는 치료용 한약 조성물을 개시한다. The present invention discloses a traditional Chinese medicinal composition for preventing and/or treating ischemia reperfusion injury; the traditional Chinese medicinal composition consists of salvianolic acids, Panax Notoginseng saponins and total saponins of Astragalus.
Bibliography:Application Number: KR20207028942